Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study - Rosenstock, J.; Goldstein, B. J.; Vinik, A. I.; O'Neill, M. Colleen; Porter, L. E.; Heise, M. A.; Kravitz, B.; Dirani, R. G.; Freed, M. I. (Diabetes, obesity & metabolism, 2006)
Keywords: Age Factors; Blood Glucose - analysis; Cholesterol - blood; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - metabolism; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; early combination treatment; elderly subjects; Female; Glipizide - administration & dosage; Glipizide - adverse effects; glycaemic control; Glycated Hemoglobin A - analysis; Humans; Hypoglycemic Agents - administration & dosage; Hypoglycemic Agents - adverse effects; Insulin Resistance; Liver - enzymology; Male; Middle Aged; rosiglitazone; Thiazolidinediones - adverse effects; Thiazolidinediones - therapeutic use; Titrimetry; Treatment Outcome; Triglycerides - blood; type 2 diabetes